Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#tecentriq
#tencentriq
#atezolizumab
#tecentriq package insert
#keytruda
#pembrolizumab
#keytruda indications
#pembrolizumab prescribing information
#keytruda prescribing information
#roche diagnostics australia pty limited
#roche australia
#roche diagnostics
#tecentric
Category
N/AGlobal Rank
N/ARank in 1 month
24.9KEstimate Value
N/ASorry. Description is not currently available
#verbindungen
#energieversorger
#tece gmbh
#tuš kanalice
#tece drainline
#deutschland
Malware Scan Info
Macafee Check : 
Email address with tecentriq.com
Recent Searched Sites
Usamedpremium.com (5 seconds ago) / US
Evledev.com (0 seconds ago) / US
Buyceps.com (15 seconds ago) / US
Tecentriq.com (0 seconds ago) / US
Rxjlvm.klubrocco.pl (1 seconds ago) / US
Hamnava.ir (33 seconds ago) / IR
Topoathletic.dk (26 seconds ago) / DK
Ledgowan-lodge-hotel-achnasheen.hotelmix.it (19 seconds ago) / US
Snaptik.app (26 seconds ago) / US
Srtip.ae (6 seconds ago) / CA
Amncat.org (6 seconds ago) / ES
Atlantadiamond.com (8 seconds ago) / US
Lacrete.ca (2 seconds ago) / US
Rxjs-dev.firebaseapp.com (9 seconds ago) / US
Xn--b1apfm1b.xn--p1ai (14 seconds ago) / RU
Upd.sev.gov.ru (23 seconds ago) / RU
Berlor-airport-inn-alajuela.ibooked.ca (12 seconds ago) / US
Milwaukeebd.com (3 seconds ago) / US
30cagr.com (14 seconds ago) / IN
Warrencustomoutdoor.com (17 seconds ago) / US
Domain Informations
Tecentriq.com lookup results from whois.safenames.net server:
- Domain created: 2014-10-31T09:36:33Z
- Domain updated: 2022-11-01T04:21:02Z
- Domain expires: 2024-10-31T09:36:33Z 0 Years, 96 Days left
- Website age: 9 Years, 269 Days
- Registrar Domain ID: 1883029341_DOMAIN_COM-VRSN
- Registrar Url: http://www.safenames.net
- Registrar WHOIS Server: whois.safenames.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +44.1908200022
- Name server:
- ALAN.NS.CLOUDFLARE.COM
- LARA.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 680673 |
| namecheap.com | 224815 |
| networksolutions.com | 166289 |
| tucows.com | 137788 |
| publicdomainregistry.com | 87644 |
| whois.godaddy.com | 62197 |
| enomdomains.com | 58093 |
| cloudflare.com | 50063 |
| namesilo.com | 48725 |
| gmo.jp | 46243 |
| register.com | 38933 |
| fastdomain.com | 38170 |
| ionos.com | 33870 |
| name.com | 32166 |
| wildwestdomains.com | 32165 |
| net.cn | 30887 |
| registrar.amazon.com | 30450 |
| dynadot.com | 28168 |
| key-systems.net | 27147 |
Host Informations
| Host name | 104.18.10.13 |
| IP address | 104.18.10.13 |
| Location | United States |
| Latitude | 37.751 |
| Longitude | -97.822 |
| Timezone | America/Chicago |
Port Scanner (IP: 104.18.10.13)
Spam Check (IP: 104.18.10.13) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with tecentriq.com on Search Engine
Tecentriq - Breastcancer.org
Tecentriq is a type of immunotherapy called an “immune checkpoint inhibitor.”. Immune checkpoints are proteins in your body that help your immune system tell the difference …
Breastcancer.orgDA: 20 PA: 34 MOZ Rank: 54
TECENTRIQ Access Solutions | Patients and Caregivers
TECENTRIQ Access Solutions is a program that helps patients taking TECENTRIQ® (atezolizumab). We can help you understand your health insurance coverage and find financial …
Genentech-access.comDA: 24 PA: 30 MOZ Rank: 55
Genentech Pro | TECENTRIQ® (atezolizumab)
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the …
Genentech-pro.comDA: 21 PA: 44 MOZ Rank: 67
Tecentriq side effects: What they are and how to manage them
More common side effects in people using Tecentriq by itself include: weakness or fatigue (lack of energy) nausea. cough. shortness of breath. decreased appetite. More …
Medicalnewstoday.comDA: 24 PA: 38 MOZ Rank: 65
TECENTRIQ® (atezolizumab) dosing and administration
For each 21-day cycle, TECENTRIQ, nab-pac, and carboplatin are administered on Day 1; in addition, nab-pac is administered on days 8 and 15. Administer the initial infusion of …
Tecentriq.globalDA: 16 PA: 36 MOZ Rank: 56
Roche | Tecentriq (atezolizumab)
Tecentriq is a monoclonal antibody designed to bind with a protein called PD-L1 expressed on tumour cells and tumour-infiltrating immune cells, blocking its interactions with both PD-1 and …
Roche.comDA: 13 PA: 50 MOZ Rank: 82
Novel Therapy-Tecentriq Combo Fails to Improve Survival in ...
Tecentriq, a monoclonal antibody that binds to the PD-L1 protein to potentially activate T cells, was the first immunotherapy that showed a survival benefit in patients with …
Curetoday.comDA: 17 PA: 50 MOZ Rank: 44
HIGHLIGHTS OF PRESCRIBING INFORMATION When administering ...
TECENTRIQ 1200 mg every 3 weeks prior to chemotherapy. •Following completion of 4 cycles of carboplatin and etoposide, administer TECENTRIQ 840 mg every 2 weeks, 1200 mg every 3 …
Accessdata.fda.govDA: 22 PA: 45 MOZ Rank: 74
Genentech: Press Releases | Tuesday, Mar 29, 2022
About Tecentriq ® (atezolizumab) Tecentriq is a monoclonal antibody designed to bind with a protein called PD-L1. Tecentriq is designed to bind to PD-L1 expressed on tumor …
Gene.comDA: 12 PA: 50 MOZ Rank: 99
Tecentriq Injection, Iv Infusion, Solution, Concentrate ...
Tecentriq leaves the PD-L2/PD-1 interaction intact. In syngeneic mouse tumor models, blocking PD-L1 activity resulted in decreased tumor growth. Tecentriq is a …
Medicinesfaq.comDA: 20 PA: 16 MOZ Rank: 45
Pronunciation of the word(s) "Tecentriq". - YouTube
Pronunciation of the word(s) "Tecentriq".Subscribe to the Channel to stay updated with the latest terms that are added on a regular basis.Thank you!
Youtube.comDA: 15 PA: 6 MOZ Rank: 31
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| takumaboutikhotel.com | domains2.squarespace.com | 101 Days |
| curiouschloride.com | publicdomainregistry.com | 40 Days |
| game1566.com | xinnet.com | 139 Days |